GREENLAND MINES LTD Conversion of Stock, Shares Converted
GREENLAND MINES LTD (GRML) reported Conversion of Stock, Shares Converted of 1 shares for the 12-month period ending 2025-12-31, per its 10-K/A filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2026-08-14
- GREENLAND MINES LTD conversion of stock, shares converted for the quarter ending 2025-12-31 was 0.00 shares.
- GREENLAND MINES LTD conversion of stock, shares converted for the quarter ending 2025-09-30 was 0.00 shares.
- GREENLAND MINES LTD conversion of stock, shares converted for the quarter ending 2025-06-30 was 0.00 shares.
- GREENLAND MINES LTD conversion of stock, shares converted for the quarter ending 2025-03-31 was 1.00 shares, a 100.00% decline year-over-year.
- GREENLAND MINES LTD conversion of stock, shares converted for fiscal 2025 was 1.00 shares, a 0.00% change from fiscal 2024.
- GREENLAND MINES LTD conversion of stock, shares converted for fiscal 2024 was 1.00 shares, a 100.00% decline from fiscal 2023.
- GREENLAND MINES LTD conversion of stock, shares converted for fiscal 2023 was 2.88M shares.
| Period end | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 6 month | Conversion of Stock, Shares Converted 9 month | Conversion of Stock, Shares Converted 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-14 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-14 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-14 | 1.00 shares 10-K/A · filed 2026-08-14 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-13 | 1.00 shares 10-Q · filed 2025-11-13 | 1.00 shares derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | 1.00 shares 10-Q · filed 2025-08-18 | 1.00 shares derived: sum of 3 quarters · filed 2025-08-18 | 1.00 shares derived: sum of 4 quarters · filed 2025-08-18 |
| 2025-03-31 | 1.00 shares 10-Q · filed 2025-05-15 | 1.00 shares derived: sum of 2 quarters · filed 2025-05-15 | 1.00 shares derived: sum of 3 quarters · filed 2025-05-15 | -2.87M shares derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 0.00 shares derived: sum of 2 quarters · filed 2025-03-31 | -2.87M shares derived: sum of 3 quarters · filed 2025-03-31 | 1.00 shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | -2.87M shares derived: sum of 2 quarters · filed 2024-11-19 | 1.00 shares 10-Q · filed 2024-11-19 | 1.00 shares derived: sum of 4 quarters · filed 2024-11-19 |
| 2024-06-30 | -2.87M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | 1.00 shares 10-Q · filed 2024-08-19 | 1.00 shares derived: sum of 3 quarters · filed 2024-08-19 | 1.00 shares derived: sum of 4 quarters · filed 2024-08-19 |
| 2024-03-31 | 2.88M shares 10-Q · filed 2024-05-23 | 2.88M shares derived: sum of 2 quarters · filed 2024-05-23 | 2.88M shares derived: sum of 3 quarters · filed 2024-05-23 | |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-17 | 0.00 shares derived: sum of 2 quarters · filed 2024-04-17 | 2.88M shares 10-K · filed 2024-04-17 | |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | 2.88M shares 10-Q · filed 2023-11-17 | ||
| 2023-06-30 | 2.88M shares 10-Q · filed 2023-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |